首页|期刊导航|中华医学杂志(英文版)|Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension

Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertensionOACSTPCD

Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension

Jiawei Song;Jianqiong Tang;Zhenzhou Zhang;Ying Liu;Jiuchang Zhong

Heart Center and Beijing Key Laboratory of Hypertension,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,ChinaDepartment of Critical Care Medicine,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 201600,ChinaHeart Center and Beijing Key Laboratory of Hypertension,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,ChinaHeart Center and Beijing Key Laboratory of Hypertension,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,ChinaBeijing Institute of Respiratory Medicine,Beijing 100020,China

ElabelaApelinAPJHypertensionRenin-angiotensin system

ElabelaApelinAPJHypertensionRenin-angiotensin system

《中华医学杂志(英文版)》 2022 (9)

1019-1026,8

This study was supported by the grants from the General Program and the National Major Research Plan Training Program of the National Natural Science Foundation of China(No.81770253 and No.91849111)and the Shanghai Sailing Program(No.20YF1444100).

10.1097/CM9.0000000000001766

评论

您当前未登录!去登录点击加载更多...